Strategic investments in intellectual capital will attract venture capital
This blog post is part of Signal’s eighth annual blog carnival
Scientists create “cloaked” donor cell and tissue grafts that escape rejection by the immune system
New research could transform cell therapies for incurable diseases
Teams focused on cell therapy and diagnostics win first and second place at the Building a Biotech Venture Pitch Competition
Myoxa Therapeutics and Specifix Dx win the Building a Biotech Venture Pitch Competition
New Medicine by Design-supported research shows mature heart cells perform well in transplants
Study is an important step forward in researchers’ understanding of treating damaged hearts with cell therapies.
New Medicine by Design-funded research advances an under-skin cell therapy for type 1 diabetes
Research shows that transplanted pancreatic cells were able to survive in animal hosts.
Medicine by Design-funded researchers develop cell injection technique that could help reverse vision loss
The technique could point the way toward new treatments with the potential to reverse forms of vision loss that are currently incurable.
Medicine by Design-funded researchers devise new strategy to improve the safety of cell therapies
Finding inspiration from an unlikely source, a team led by Andras Nagy at Sinai Health System has an answer for one of the most pressing questions in cell therapy: how to ensure its safety
Medicine by Design researchers clear hurdles toward robust supply of stem cells for research and therapy
Paper identifies new combination of factors that allow scientists to grow stem cells in lab on much larger scale than previously possible
Interdisciplinary research team tackles remaining hurdles to using stem cells to reverse heart failure
Medicine by Design-funded project aims to fast-track cardiac cell therapy to clinical trials